BR
BioRegenx, Inc.
BRGX · OTC
$0.01 -31.25% (-$0.00)
1M -21.32%
Market Cap $7.77M
P/E Ratio -
Div. Yield -
ROE -
Piotroski F-Score Moderate
5/9Valuation
12 /100
Expensive P/FCF 412.34x
P/S 4.40x
EV/FFO N/A
Growth
100 /100
Growing Rev. growth 253.00%
Book val. growth N/A
EPS growth N/A
Profitability
24 /100
Weak Op. margin 21.30%
Gross margin 81.90%
FCF margin 1.07%
Quality
79 /100
Excellent Asset turnover 5.24x
ROIC 22.55%
ROA 386.56%
Debt
0 /100
High Int. coverage -1.24x
Current ratio 0.05x
Debt/Assets N/A
Stability
13 /100
Unstable EPS volatility 488.95%
Beta -2.74x
Profitable years 0
Bulios Scoring descrie calitatea și istoricul unei companii, nu randamentul viitor. Un scor ridicat nu este un semnal de cumpărare. Află mai multe
Întreabă StockBot despre BRGX
Online
Sector
Healthcare
Industry
Medical - Instruments & Supplies
CEO
William Resides
Employees
6
Headquarters
Chattanooga